Melero, I. (., Calvo, E. (., Goebeler, M. (. E., Garralda, E. (., Dummer, R. (., Ruiz-Rodríguez, M. (. J., . . . Leo, E. (. (2021). A phase I, first-in-human clinical trial of the GDF-15 neutralizing antibody CTL-002 in subjects with advanced stage solid tumors (Acronym: GDFATHER).
Citação norma ChicagoMelero, I. (Ignacio)|||/items/82113ea8-7ce1-49d5-9ee3-42cf20db1c4e, et al. A Phase I, First-in-human Clinical Trial of the GDF-15 Neutralizing Antibody CTL-002 in Subjects With Advanced Stage Solid Tumors (Acronym: GDFATHER). 2021.
Citação norma MLAMelero, I. (Ignacio)|||/items/82113ea8-7ce1-49d5-9ee3-42cf20db1c4e, et al. A Phase I, First-in-human Clinical Trial of the GDF-15 Neutralizing Antibody CTL-002 in Subjects With Advanced Stage Solid Tumors (Acronym: GDFATHER). 2021.